Thursday, July 26, 2007

Foresight Is 20/20

Adults choose eye-glasses based mostly on fit and style. But kids' glasses have to withstand the abuses of tree climbing, the playground and boisterous games of tag. For kids younger than 10, David Coats, an ophthalmologist at Houston's Texas Children's Hospital, recommends frames made of plastic, because they're "more likely to withstand a blunt force." Choose clear, impact-resistant lenses made of Trivex ($70 to $150) or polycarbonate ($50 to $100), which also have the bonus of providing 100 percent UVA and UVB protection. Stuart Danker, a pediatric ophthalmologist from Baltimore, also recommends photochromic lenses that darken in the sun and clear up in the shade ($65 to $90;

Pay attention to fit. Anything too big or too heavy can slide down and leave the child looking through the wrong part of the lens. Kids' heads are shaped differently from adults', and a good optician will make sure the glasses fit at three crucial points: the widest part of the face (it should match the width of the glasses), along the nose (a child's nose bridge is flatter than an adult's, and uneven weight distribution can affect nose development) and behind the ears (the frames should point straight back and wrap gently around the ear without pressing into the head). Now they can focus on fun.

By Charlene Dy

Best Hospitals

Legend for chart:

A: Rank
B: Region
C: Hospital
D: Reputation (%)


1 South
Bascom Palmer Eye Institute at the University of Miami 72.2

2 South
Wilmer Eye Institute, Johns Hopkins Hospital, Baltimore 65.0

3 Northeast
8 Wills Eye Hospital, Philadelphia 56.5

4 Northeast
Massachusetts Eye and Ear Infirmary, Boston 31.4

5 West
Jules Stein Eye Institute, UCLA Medical Center, Los Angeles 30.2

6 Midwest
University of Iowa Hospitals and Clinics, Iowa City 18.2

7 South
Duke University Medical Center, Durham, N.C. 16.2

8 West
Doheny Eye Institute, USC University Hospital, Los Angeles 15.0

9 West
University of California, San Francisco Medical Center 7.6

10 Midwest
Barnes-Jewish Hospital/Washington University, St. Louis 7.0

11 South
Emory University Hospital, Atlanta 6.9

12 Midwest
Cleveland Clinic 6.4

13 Northeast
New York Eye and Ear Infirmary 6.2

14 Northeast
New York-Presbyterian Univ. Hosp. of Columbia and Cornell 5.9

15 Midwest
Mayo Clinic, Rochester, Minn. 5.1

16 Midwest
University of Michigan Hospitals and Health Centers, Ann Arbor 4.2

17 South
Cullen Eye Institute, Methodist Hospital, Houston 3.4

U.S. News & World Report, L.P.

Friday, July 13, 2007

Examine the Top 20 Companies in Late and Early Stage of Glaucoma Projects inside

Dublin - Research and Markets has announced the addition of Ophthalmology and Optometry - Glaucoma Drug Pipeline Report to their offering

"Ophthalmology and Optometry - Glaucoma Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of glaucoma drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.

Key benefits

* Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
* Keep track of your competitors and partners by better understanding their product pipeline.
* Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
* Maintain a critical competitive advantage.

Content Outline:


Glaucoma Pipeline Overview

* -% of Projects (By Phase of Development)
* -No. of Projects by Phase of Development
* -Marketed Products Vs. Pipeline Products

Company Overview - Pipeline Projects

* -Company Overview - Pipeline Projects
* -Legend
* -Top 20 companies in late stage Glaucoma Projects
* -Top 20 companies in early stage Glaucoma Projects

Full Pipeline View

* -Pre Clinical Pipeline View
* -Phase I Pipeline View
* -Phase II Pipeline View
* -Phase III Pipeline View
* -Pending Approval Pipeline View